10:00 Fireside: Unleash the power of innovation and breakthrough technologies across Europe
Stefan Oelrich, President, Pharmaceuticals, Bayer
10:20 Panel: Discover the future of European Healthcare
Nathalie Moll, Director General, EFPIA
Iskra Reic, EVP, Europe & Canada, AstraZeneca
Meindert Boysen, Deputy Chief Executive & Director of the Centre for Health Technology Evaluation, NICE
11:00 Rare disease engagement: the template for future personalised medicine
Giles Platford, President, Europe & Canada, Takeda
11:20 In review: the European Commission’s Pharmaceutical Strategy and its impact on innovation in the future
Richard Daniell, EVP, Head of Europe Commercial, Teva
11:40 Harnessing the power of digital technologies and partnerships to change the future of healthcare in Europe
Luis Iglesias, President & Head of EMEA, Corporate Officer, Santen
12:30 Reimagine your business in the image of your customer
Marie-France Tschudin, President, Pharmaceuticals, Novartis
12:50 Uncover the future of HCP engagement to deliver unprecedented value
Liz Murray, Global Business Unit, Contract Sales & Medical Solutions, IQVIA
13:10 The best industry in the world: How the global pandemic enabled the biopharma industry to positively showcase science and innovation when it mattered most
Bill Sibold, EVP & Head, Sanofi Genzyme
13:30 Transforming health together: Co-creation between Pharma and the patient
Carinne Brouillon, Head, Human Pharma, Board of Managing Directors, Boehringer Ingelheim
13:30 Innovation inspired by patient-centric mindset and mentality: The LEO Pharma way
Catherine Mazzacco, President & CEO, LEO Pharma
13:50 Digital Transformation – Technology Driven or Business Driven?
Lokesh Jindal, Product Executive, Axtria
14:10 Sumitovant's unique business model of the future
Myrtle Potter, CEO, Sumitovant Biopharma